ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

MANAGEMENT OF HYPERTENSIVE PATIENTS WITH CARDIOVASCULAR CO MORBIDITY IN PRIMARY CARE

AUTHORS:

Yara Mofarih Assiri , Anwar Fahad Saleh Albalawi , Mohammed Naser Ahmed , Saeed Abdullah Qobti , Lojain Adel Alireda , Musaab Khalil Albalawi , Zainab Yousef Alrebh , Hadeel Salem Alwagdani , Nasser Salem Alsaidi , Noor Naif Alazmi

ABSTRACT:

Introduction: According to the current evidence and guidelines, the treatment of primary (also known as essential) hypertension is crucial to reduce the risk of cardiovascular-related complications and mortality. The WHO stated in their reports that hypertension is considered the most dangerous predisposing factor that leads to mortality and long-term morbidity in all areas of the world. They estimated that over one billion individuals around the world are hypertensive which is causing more than nine million deaths annually.Aim of work: In this review, we will discuss the most recent evidence regarding Management of hypertensive patients with cardiovascular co morbidity in primary care Methodology: We did a systematic search for Management of hypertensive patients with cardiovascular co morbidity in primary care using PubMed search engine (http://www.ncbi.nlm.nih.gov/) and Google Scholar search engine (https://scholar.google.com). We only included full articles.Conclusions: Hypertension is considered to be the most important risk factor of developing cardiovascular diseases, and an important factor leading to serious morbidity and mortality. Many patients with hypertension are considered to be high-risk patients, meaning that they have a significantly higher risk of developing cardiovascular complications due to their hypertension. These patients must follow strict management in order to decrease their risks of developing cardiovascular diseases. Key words: hypertension, management, cardiovascular comorbidity

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.